Alkim Alkali Kimya A.S.

As of June 30, 2026, Alkim Alkali Kimya A.S. carries a market capitalization of 5.35B, placing it among publicly traded companies globally. Its enterprise value stands at 5.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Alkim Alkali Kimya A.S.'s next confirmed earnings release is scheduled for November 10, 2026.

As of June 30, 2026, Alkim Alkali Kimya A.S. has 300.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.99, and the price-to-book ratio stands at 1.10.

As of June 30, 2026, Alkim Alkali Kimya A.S. trades at an EV/EBITDA multiple of 19.31 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 165.82 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.76B versus a market cap of 5.35B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Alkim Alkali Kimya A.S. maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.22, indicating elevated leverage, while an interest coverage ratio of 7.26 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Alkim Alkali Kimya A.S. posted a negative return on equity (ROE) of -10.10, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.70, reflecting losses generated across the asset base. The company generates approximately 12.17M in revenue per employee across its workforce of 446.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.90 indicates how many times Alkim Alkali Kimya A.S. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Alkim Alkali Kimya A.S. recorded 204.96M in income tax expense. The company reported a pretax loss of -269.56M and -451.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Alkim Alkali Kimya A.S.'s stock has declined approximately 46.81% over the past 52 weeks. The 50-day moving average sits at 13.69, while the 200-day moving average is 17.06.

Over the twelve months ended June 30, 2026, Alkim Alkali Kimya A.S. generated 5.43B in revenue and converted that into -451.32M in net income, yielding earnings per share of -1.58. EBITDA reached 298.12M, while operating income came in at -16.10M.

As of June 30, 2026, Alkim Alkali Kimya A.S. holds 440.60M in cash and equivalents against 529.85M in total debt, resulting in a net debt position of 89.25M. Total book value stands at 4.87B, with working capital of 861.31M providing operational flexibility.

Alkim Alkali Kimya A.S. produced 823.83M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -622.27M in capital expenditures, free cash flow totaled 201.56M - equivalent to 0.67 per share.

Over the twelve months ended June 30, 2026, Alkim Alkali Kimya A.S. posted a gross margin of 9.50, reflecting its pricing power and cost economics. The operating margin of -0.30 and net profit margin of -8.31 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 3.77, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.58, meaning Alkim Alkali Kimya A.S. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Alkim Alkali Kimya A.S.'s most recent stock split took place on December 9, 2024 with a 1:2 split ratio.

As of June 30, 2026, Alkim Alkali Kimya A.S. has an Altman Z-Score of 2.43, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.